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A B S T R A C T
The aim of this study was to provide decision makers with an assessment of potential future health effects of
interventions against overweight and obesity (OWOB). By means of the DYNAMO-HIA tool we conducted a
health impact assessment simulating future prevented disease (ischemic heart disease (IHD), diabetes, stroke,
and multi morbidity) incidence, prevalence and life expectancy (LE) related to a scenario where OWOB is re-
duced by 25% and a scenario where obesity is eliminated. The study covered projected number of persons living
in Copenhagen, Denmark during year 2014–2040 (n 2040 = 742,129). Reducing the proportion of men/women
with OWOB with 25% will increase population LE by 2.4/1.2 months and at the same time decrease LE with
diabetes by 3.1/2.2 months. As a result of eliminating obesity, total LE will increase by 6.0/3.6 months and LE
with diabetes will decrease with 9.8/10.3 months for men/women. We found no important effects on LE with
IHD and stroke. This illustrates that the positive effects of lowering OWOB levels on IHD and stroke incidence is
offset due to increasing total LE. Although the population of Copenhagen is relatively lean, reducing obesity
levels will result in significant benefits for population cardiometabolic health status and LE. Future public health
prevention programs may use the results as reference data for potential impact of reductions in OWOB.
1. Introduction
Obesity defined by a body-mass-index (BMI) above 30 is associated
with reduced quality of life, adverse health outcomes and lower life
expectancy (Ogden et al., 2007). As a result of improvements in medical
and clinical treatment, death ascribed to and obesity-related diseases
covering amongst others diabetes and ischemic heart disease (IHD)
have decreased. Thus, these diseases often become chronic and lifelong.
Obesity is now the fourth leading cause of loss in Disability-Adjusted
Life Years (DALYs) worldwide, and in Denmark accounting for 6.6% of
DALYS after smoking, high systolic blood pressure and alcohol misuse
(GBD Compare, n.d.). The World Health Organization has stated in the
European Food and Nutrition Action Plan for 2015–2020 to halt the
increase in obesity (WHO regional office for Europe, 2014). In Co-
penhagen Municipality, Denmark, obesity increased over a period of
17 years (1987–2004) by 4.3% annually (Juel and Ekholm, 2015) and
has in recent years reached a plateau (Stockmarr et al., 2016). Today,
the proportion of persons with obesity in Copenhagen is 11% among
men and women (Lau et al., 2015). Although the health benefits of
weight reductions at the individual level is well-established (Ogden
et al., 2007), less is known about the effects of reducing population
obesity prevalence on future development of diseases and the con-
sequences for future provision of healthcare (Levy et al., 2011).
In the planning phase of population prevention programs estimated
health gains typically involve analyses that require a wide range of data
including information on demography, lifestyle, disease, mortality, and
epidemiological evidence. Health impact assessment (HIA) tools have
been developed to support researchers and public health authorities
(Kemm, 2008). Such tools model the dynamic relations between the
distribution of risk-factor exposures in the population, and disease and
mortality outcomes. HIAs are attracting more attention within public
health planning and policy and have been used in single cases for
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several decades in for instance members of the Healthy Cities Network
(Kemm, 2013), and are in addition being rolled out as stand-alone ac-
tivity in several countries (e.g. England) (WHO, 2013). Relatively few
studies have simulated long-term health effects of changes in health
behavior by means of dynamic quantitative HIAs, among these three
studies simulating the consequences of obesity on population disease
and mortality (Boshuizen et al., 2012; Lhachimi et al., 2013, 2016).
Thus, simulation models of future prevalence of disease remain un-
derutilized in chronic disease prevention research (Smith et al., 2014).
The aim of this study is to make projections of changes in incidence
and prevalence of diabetes, IHD, stroke and multi-morbidity (combi-
nations of the three diseases) according to the three overweight and
obesity (OWOB) scenarios; a. no change in BMI (reference); b. OWOB
reduction and c. eliminating obesity. Additionally, the aim was to to
quantify potential gains in life expectancy by year 2040.
Scenario b., in which a 25% reduction in population OWOB pre-
valence is modelled, approximately corresponds to an annual decrease
of 1%. We consider this to be an ambitious but realistic development if
preventive actions are being implemented. To illustrate the full po-
tential health gains, scenario c. estimates effects of eliminating obesity
while keeping prevalence of overweight constant. To quantify expected
effects of scenario b. and c. results are compared with scenario a. (re-
ference) in which OWOB levels stay constant over time.
Fig. 1. a–c. Projected disease incidence rates (cases pr. 100.000 persons) development year 2014–2040, adjusted to year 2040 age distribution.
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2. Methods
2.1. The DYNAMO-HIA model
DYNAMO-HIA is a Markov-type model; a dynamic simulation model
that projects development in morbidity and mortality. It uses micro-
simulation for risk-factor modelling which is combined with macro-si-
mulation for calculating disease prevalence (Boshuizen et al., 2012).
Conceptually, DYNAMO-HIA links risk-factor states to transition prob-
abilities, which define the likelihood that an individual in a specific
risk-factor state will shift to another risk-factor state over time (e.g. the
probability an overweight person attaining normal body weight)
(Lhachimi et al., 2012). Simulations follow the assumed causal
pathway, in which population risk-factor exposure is linked to in-
cidence of one or more diseases and mortality by use -of relative risks.
For example, in the case of two diseases, there are four health states: the
probability of having neither disease, only one of the diseases, or both
diseases (Boshuizen et al., 2012). One or more counterfactual scenarios
are used as benchmarks, in which the population-risk-factor-prevalence
is set to a new level (e.g. goals set by politicians or analysts). These
benchmark scenarios are compared to a reference scenario, typically
with future risk-factor prevalence at a level reflecting current risk-factor
development. The reference and counterfactual scenario(s) are mod-
elled independently from another, and can be defined such that the new
risk-factor levels are reached gradually over the simulation period, and
health effects of the risk-factor exposure levels alike are developing
over time (Lhachimi et al., 2012).
2.2. Data
Input data cover projections of population distribution from
Statistics Denmark, data on morbidity based on hospital contacts
(Schmidt et al., 2015) and mortality from Danish administrative reg-
isters (Pedersen, 2011), data on BMI class distribution from the 2013
Copenhagen Country Health Profile (Robinson et al., 2014), and re-
lative risks from the literature linking OWOB to disease, and disease to
other diseases and mortality. Following, these input data are described
in detail.
Data on disease and mortality was linked by means of unique person
identifiers given at birth or immigration. In Denmark researchers are
entitled to use registers for research purposes without persons' informed
consent as long as the researchers comply with predefined research
regulations. Calculation of incidence, prevalence and excess mortality
were based on all persons who had lived in Copenhagen Municipality at
some time within a 15-year period. Persons were censored at death or
emigration. As the DYNAMO-HIA model uses input data stratified in 1-
year age and- sex-groups and as several population strata had few
observations, we smoothed out input data irregularities before they
were included in the model.
IHD and stroke: Data on IHD (ICD-10: I20-I25) and stroke (ICD-10:
I60-I69, G45) was taken from the Danish National Patient Register
(LPR) on hospital contacts (Schmidt et al., 2015) and from the Cause of
Death Register (Helweg-Larsen, 2011). The disease prevalence was
given as the number of persons with at least one diagnosis in the period
from Jan 1st 2000 to Dec 31st 2014. Incident cases were persons with a
diagnosis in the period from Jan 1st 2010 to Dec 31st 2014 among
persons with no diagnosis of the specific disease in the preceding ten
years, and was calculated as cases per person-years at risk. Disease
status was merged with mortality data, and excess mortality rates were
calculated as the difference in death rates (deaths/person-years) for
people with and without IHD/stroke in the period Jan 1st 2010–Dec
31st 2014.
Diabetes: Data on diabetes was obtained from the Danish Diabetes
Register (Jørgensen et al., 2016) and included both type 1 and type 2
diabetes mellitus. The register includes information on all persons re-
gistered with diabetes in any of the relevant Danish national registers
(e.g. hospitalization and prescription registers). We did not have access
to diabetes data after Dec 31st 2012. The disease prevalence was given
as the number of persons registered during the period Jan 1st 2000 to
Dec 31st 2012. Incident cases were defined as persons with a diagnosis
in the period Jan 1st 2010 to Dec 31st 2012 among persons with no
diabetes diagnosis in the preceding ten years. Disease status was
merged with mortality data, and excess mortality rates were calculated
as the difference in death rates (deaths/person-years) for people with
and without the disease in the period Jan 1st 2010 to Dec 31st 2012.
All-cause mortality: Date of death was obtained from the Central
Personal Register for the period Jan 1st 2000 to Dec 31st 2014
(Pedersen, 2011). Death rates were given as deaths/person-years at
risk.
BMI class distribution: Self-reported questionnaire data from the
2013 Copenhagen County Health Profile (Robinson et al., 2014)
(n = 9,265, persons aged 16 + years) was used to calculate BMI
(weight (kg)/height (m)2). Persons were categorized as normal weight
(BMI ≤ 24.9), overweight (BMI = 25–29.9) or obese (BMI ≥ 30).
Among the respondents of the survey (overall response rate 52.3%),
72.3% completed the items on height and weight (Christensen et al.,
2012). Weighting was done according to gender, age, socioeconomic
position, ethnicity and health by Statistics Denmark.
Risk from one disease to another disease:We used age- and sex-specific
relative risks from meta-analyses causally connecting diabetes to myo-
cardial infarction (Yusuf et al., 2004) and diabetes to stroke (Barrett-
Connor and Khaw, 1988) (Please see supplementary data S1 for a list of
relative risks).
Risk of disease and death from OWOB: Data on age and sex specific
relative risks from BMI classes on IHD, diabetes and stroke was ob-
tained from peer reviewed scientific research papers, meta-analyses and
additional material such as governmental reports collected for use in
the DYNAMO-HIA database (Consortium, 2010) (See S1 for a list of
relative risks).
In the future, Statistics Denmark expects proportionally more elder
persons and more children living in Copenhagen Municipality (see S1
for year 2014 and 2040 population sex- and age-distributions). These
projections of future population composition are based on current and
past composition on gender, age, country of origin, as well as fertility,
mortality and migration. Therefore, the results from the simulation
models have been sex- and age-adjusted to the projected population
distribution of year 2040 (men = 365,480; women = 376,650).
2.3. Definition of reference and counterfactual scenarios
We decided on building two counterfactual scenarios in addition to
the reference scenario;
Table 1
Projected incident disease (cases pr. 100,000 persons) in year 2040.
Cases, n Difference from reference scenario, n
(%)
IHD Diabetes Stroke IHD Diabetes Stroke
Men
Reference 449 408 400 – – –
Obesity reduction 431 370 390 −19 (−4) −38 (−9) −10 (−2)
Eliminate obesity 400 314 371 −50 (−11) −93 (–23) −29 (−7)
Women
Reference 321 311 364 – – –
Obesity reduction 313 288 358 −8 (−3) −24 (−8) −6 (−2)
Eliminate obesity 289 232 341 –32 (−10) −79 (−25) −24 (−6)
IHD, Ischaemic Heart Disease.
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- No change in BMI class distribution, which is referred to as reference
scenario.
- Reduction in population OWOB prevalence by 25%, which is re-
ferred to as obesity reduction scenario.
- Total elimination of obesity, which is referred to as eliminate obe-
sity scenario. (See S1 for BMI class development and BMI distribu-
tion of the three scenarios).
The transition probabilities estimated internally by DYMANO-HIA
will assure that in future years the BMI class prevalence of the reference
scenario according to age and sex is the same as in year 2013 (van de
Kassteele et al., 2012). The two counterfactual scenarios, are gradually
implemented over the period 2014–2040 and reflect partly that fewer
persons get OWOB (lower transition from normal to overweight and
overweight to obese), partly that persons lose weight (higher transition
from obesity to overweight and from overweight to normal weight). We
set the prevalence rates to be effectuated in year 2040 and let the
DYNAMO-HIA calculate the yearly transition rates between BMI
classes.
3. Results
In Copenhagen Municipality, decreasing population OWOB pre-
valence has potential to reduce the incidence of IHD, stroke and dia-
betes substantially from year 2014 to 2040 (Fig. 1a–c).
IHD, diabetes and stroke incidence rates are higher for men than for
women. Among men, the incidence of IHD is expected to stagnate and
incidence of stroke is expected to increase in the reference scenario but
is turned into a downwards trend in the obesity reduction and eliminate
obesity scenarios.
In Tables 1 and 2, estimated disease incidence rates and prevalence
proportions are displayed for the reference, obesity reduction and
eliminate obesity scenarios in year 2040. In absolute numbers, we find
the largest effects on diabetes incidence and prevalence. Approximately
23% fewer men and 25% fewer women are estimated to have diabetes
in year 2040 in the eliminate obesity scenario. Despite significant re-
ductions in IHD and stroke incidence from reductions in obesity, in-
cremental increases in prevalence of IHD and stroke as single standing
diseases is estimated. This is likely to be ascribed to increasing life
expectancy (Table 3). Multi morbidity, co-occurrence with two or more
of the three diseases IHD, diabetes and stroke is common. For example,
48% of men and 39% of women with stroke are also diagnosed with
IHD and/or diabetes, and the relative gains from reducing obesity are
larger for multi morbidity than for any of the diseases individually. The
relative effects of eliminating obesity on multi morbidity; combinations
of IHD, diabetes and stroke, corresponded to an estimated 19% re-
duction in prevalent cases.
Large differences in life expectancy exist between men and women
(Table 3). At birth, women are expected to live 4.8-years longer than
men. Overall, men compared to women, can expect more years with
IHD and diabetes, while women live more years with stroke which is
partly explained by the steep increase in stroke with higher age. Re-
ducing the proportion of persons with obesity not only increases the
total life expectancy, but also increases disease-free life expectancy.
Elimination of obesity increases life expectancy by more than three
months among women and six months among men when compared
with in the reference scenario.
4. Discussion
We simulated three scenarios of OWOB development from 2014 to
2040 and assessed the effects on life expectancy and cardiometabolic
disease (IHD, diabetes and stroke) in 2040. Results were obtained by
use of the DYNAMO-HIA model and we have not been able to identify
other papers using dynamic simulations methods to quantify future
prevalence of multi morbidity related to changes in OWOB develop-
ment. Though Copenhagen Municipality has low and stable levels of
OWOB, obesity is still one of the leading causes of chronic disease and
reducing OWOB or eliminating obesity was estimated to reduce cardi-
ometabolic disease incidence markedly. The results suggest that in-
cidence of cardiometabolic disease is postponed for a subgroup of the
population, and with the extended life also followed increasing disease-
free life expectancy. As the risk-factor targets were reached by the end
of the simulation period, and as the full health effects of changes in
OWOB levels can be registered many years after these changes, ex-
pected effects of the reductions in OWOB will be larger when expanding
the projection period. Incremental increase in future stroke and IHD
cases was estimated, but this is partly explained by a modest increase in
population life expectancy combined with higher incidence of stroke
and IHD with increasing age.
We searched the literature for examples of interventions that suc-
ceeded in reducing OWOB at the population level. Despite the existence
of a handful of population based multifactorial lifestyle interventions
(Krogsbøll et al., 2012), they did not succeeded in reducing OWOB at
the population level. Neither could the scenarios be based on OWOB
levels of other countries, as Denmark has the lowest levels amongst
comparable countries (Lhachimi et al., 2016). Policy led solutions, such
as laws and regulations are amongst the most powerful instruments for
sustainable health behavior change, with the potential to affect entire
populations (Jørgensen et al., 2013). There is currently little evidence
in support of a regulatory approach to addressing obesity (e.g. taxation
of unhealthy food, enhancing places for physical recreation and re-
striction of advertising) (Jørgensen et al., 2013), but this should pri-
marily be explained by the absence of these (Walls et al., 2011). Rea-
sons for this reluctance to enact policy led solutions include amongst
others the powerful lobby represented by the food industry (Swinburn
et al., 2011). Regulation and law enforcements in many other areas, for
example seat belt use, smoking and vaccinations, has resulted in im-
portant health benefits (Capewell and Capewell, 2017).
Table 3
Projected life expectancy at birth (years), total and with disease, in year 2040.
Difference from referemce scenario, years (%)
Total LE IHD Diabetes Stroke Total LE IHD Diabetes Stroke
Men
Reference 76.6 6.4 6.6 4.9 – – – – – – – –
Obesity reduction 76.7 6.3 6.3 4.9 0.2 (0.2) −0.09 (−1.4) −0.26 (−4.0) −0.03 (−0.5)
Eliminate obesity 77.1 6.1 5.8 4.8 0.5 (0.6) −0.30 (−4.6) −0.82 (−12.4) −0.09 (−1.9)
Women
Reference 81.4 5.5 6.0 5.3 – – – – – – – –
Obesity reduction 81.4 5.4 5.8 5.3 0.1 (0.1) −0.06 (−1.0) −0.18 (−3.0) −0.02 (−0.5)
Eliminate obesity 81.6 5.2 5.1 5.1 0.3 (0.3) −0.27 (−5.0) −0.86 (−14.4) −0.15 (−2.8)
LE = Life expectancy. IHD = Ischaemic Heart Disease.
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4.1. Study limitations and strengths
It is a strength that data on population distribution, disease and BMI
class distribution originated from Copenhagen Municipality and all data
on disease and mortality were from Danish nationwide registers.
Information on BMI from population health surveys was weighted for
non-response to reflect the distribution in the general population.
Additionally, diabetes disease status was obtained by combining in-
formation from several registers, reducing the risk of differential mis-
classification. Advantages related to the DYNAMO-HIA model are
multistate projections of disease (including multi morbidity) and mor-
tality (Boshuizen et al., 2017). Thus, compared to more conventional
forecasting models, DYNAMO-HIA takes a causal-network approach to
disease development. Weaknesses regarding the simulation model are
the assumption of relative risks to be stationary and other risk-factors
are kept constant over time. Studies have suggested that the relative
risk from obesity on health may vary over time. Azfall et al. for example
find that the BMI level associated with the lowest risk of all-cause
mortality has shifted from BMI 22.7 to 27.0 in the period 1976–2013
and comparable trends were observed for morbidity (Afzal et al., 2016).
Period effects related to changes in clinical practice, such as improved
treatments (e.g. technology offering personalized monitoring of disease
status), may explain why the obesity related morbidity has decreased
and this trend is likely to continue in the future (Vasan and Benjamin,
2016). On the other hand, a reduction in competing risk-factors such as
smoking and air pollution may increase future deaths attributed to
obesity.
5. Conclusions
A quantitative HIA was conducted to simulate and compare future
health effects of three obesity scenarios (no change (reference), OWOB
reduction, eliminate obesity) which were gradually implemented the
period 2014–2040. Large reductions in cardiometabolic disease in-
cidence and life years with diabetes is estimated as an effect of reducing
OWOB. Despite isolated areas of improvement, no country has to date
reversed its obesity epidemic (Svendstrup et al., 2011). The results of
the study should be used as an illustration of the extent of future disease
cases and life years related to OWOB, but also to motivate and present
to public health planners the potential benefits from OWOB prevention.
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